rs1348390859
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021098.3(CACNA1H):c.6488G>C(p.Gly2163Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000131 in 1,530,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2163R) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.6488G>C | p.Gly2163Ala | missense_variant | Exon 35 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.6503G>C | p.Gly2168Ala | missense_variant | Exon 34 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.6473G>C | p.Gly2158Ala | missense_variant | Exon 34 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.6470G>C | p.Gly2157Ala | missense_variant | Exon 34 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.6470G>C | p.Gly2157Ala | missense_variant | Exon 35 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.6455G>C | p.Gly2152Ala | missense_variant | Exon 35 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.6449G>C | p.Gly2150Ala | missense_variant | Exon 35 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.6437G>C | p.Gly2146Ala | missense_variant | Exon 34 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.6431G>C | p.Gly2144Ala | missense_variant | Exon 34 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.6381G>C | p.Arg2127Arg | synonymous_variant | Exon 36 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.6330G>C | p.Arg2110Arg | synonymous_variant | Exon 35 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.6303G>C | p.Arg2101Arg | synonymous_variant | Exon 36 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*2407G>C | non_coding_transcript_exon_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*1536G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*4306G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5932G>C | non_coding_transcript_exon_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*1429G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*1347G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*2067G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*1155G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*1122G>C | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.*402G>C | non_coding_transcript_exon_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.6488G>C | non_coding_transcript_exon_variant | Exon 35 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.6455G>C | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*1604G>C | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711483.1 | c.*402G>C | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.*402G>C | 3_prime_UTR_variant | Exon 34 of 34 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*2407G>C | 3_prime_UTR_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*1536G>C | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*4306G>C | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5932G>C | 3_prime_UTR_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*1429G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*1347G>C | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*2067G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*1155G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*1122G>C | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.*402G>C | 3_prime_UTR_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*1604G>C | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000621827.2 | n.6121+367G>C | intron_variant | Intron 35 of 36 | 6 | ENSP00000518766.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000638 AC: 1AN: 156796 AF XY: 0.0000115 show subpopulations
GnomAD4 exome AF: 7.25e-7 AC: 1AN: 1378794Hom.: 0 Cov.: 35 AF XY: 0.00000147 AC XY: 1AN XY: 680762 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74362 show subpopulations
ClinVar
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces glycine with alanine at codon 2163 of the CACNA1H protein (p.Gly2163Ala). The glycine residue is weakly conserved and there is a small physicochemical difference between glycine and alanine. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with CACNA1H-related disease. This variant is not present in population databases (ExAC no frequency). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at